DEMAPHARMA

Ottignies-Louvain-la-Neuve ·KBO/BCE: BE 0885.178.745

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Metric	This company	Sector median	Position in the sector
Solvency	53.4%	17.4%	better than 83% of 857 sector peers
Net result	€24k	€15k	better than 55% of 858 sector peers
Equity	€368k	€102k	better than 75% of 859 sector peers
Gross operating margin	€129k	€214k	better than 36% of 786 sector peers
Staff costs	€46k	€220k	higher than 15% of 707 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€690k
Fixed assets	21/28	€662k
Tangible fixed assets	22/27	€204k
Financial fixed assets	28	€457k
Current assets	29/58	€28k
Amounts receivable within one year	40/41	€11k
Investments	50/53	€11k
Cash & bank	54/58	€4k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€690k
Equity	10/15	€368k
Contributions / capital	10/11	€19k
Reserves	13	€349k
Amounts payable	17/49	€322k
Amounts payable after one year	17	€248k
Amounts payable within one year	42/48	€74k
Trade debts payable within one year	44	€2k
Income statement
Gross operating margin	9900	€129k
Operating result	9901	€51k
Financial charges	65	€19k
Result before taxes	9903	€32k
Income taxes	67/77	€7k
Net result for the period	9904	€24k
Result to be appropriated	9905	€24k

Summary